| Dr Adrian William Jachens, MD | |
|
1200 E Ridgewood Ave, Ridgewood, NJ 07450-3957 | |
| (201) 612-4400 | |
| (201) 612-9446 |
| Full Name | Dr Adrian William Jachens |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 16 Years |
| Location | 1200 E Ridgewood Ave, Ridgewood, New Jersey |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063673408 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | P2684 (Texas) | Secondary |
| 207W00000X | Ophthalmology | 25MA09305700 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Adrian W Jachens Md Llc | 6406252600 | 2 |
News Archive
Researchers from 12 Spanish hospitals took part with the aim of uncovering clinical and prognostic characteristics in solid organ recipients with COVID-19. The conclusions underscore the need for strict preventive measures in the initial period after transplantation.
In this post in the Chicago Council on Global Affairs' "Global Food For Thought" blog, Howarth Bouis, director of HarvestPlus, a global research program that develops and disseminates nutrient-rich staple food crops to improve nutrition globally, writes, "David Cameron's decision to tie a hunger summit to the Olympics was imaginative ... because Cameron saw how the Olympics, that celebrate the best of human athleticism and teamwork, could also be used to draw attention to those who will never ever come close to competing in an Olympics event."
Celgene Corporation and Avila Therapeutics, Inc., a privately held biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, today announced a definitive merger agreement under which Celgene Corporation will acquire Avila Therapeutics, Inc.
Using experimental models, researchers at Boston University School of Medicine (BUSM) showed that adenosine, a metabolite released when the body is under stress or during an inflammatory response, stops the process of adipogenesis, when adipose (fat) stem cells differentiate into adult fat cells.
› Verified 4 days ago
| Entity Name | Scott B. Pomerantz, Md |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982890422 PECOS PAC ID: 5395788087 Enrollment ID: O20050603000371 |
News Archive
Researchers from 12 Spanish hospitals took part with the aim of uncovering clinical and prognostic characteristics in solid organ recipients with COVID-19. The conclusions underscore the need for strict preventive measures in the initial period after transplantation.
In this post in the Chicago Council on Global Affairs' "Global Food For Thought" blog, Howarth Bouis, director of HarvestPlus, a global research program that develops and disseminates nutrient-rich staple food crops to improve nutrition globally, writes, "David Cameron's decision to tie a hunger summit to the Olympics was imaginative ... because Cameron saw how the Olympics, that celebrate the best of human athleticism and teamwork, could also be used to draw attention to those who will never ever come close to competing in an Olympics event."
Celgene Corporation and Avila Therapeutics, Inc., a privately held biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, today announced a definitive merger agreement under which Celgene Corporation will acquire Avila Therapeutics, Inc.
Using experimental models, researchers at Boston University School of Medicine (BUSM) showed that adenosine, a metabolite released when the body is under stress or during an inflammatory response, stops the process of adipogenesis, when adipose (fat) stem cells differentiate into adult fat cells.
› Verified 4 days ago
| Entity Name | Parsippany Eyecare Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629061825 PECOS PAC ID: 5193807808 Enrollment ID: O20080201000427 |
News Archive
Researchers from 12 Spanish hospitals took part with the aim of uncovering clinical and prognostic characteristics in solid organ recipients with COVID-19. The conclusions underscore the need for strict preventive measures in the initial period after transplantation.
In this post in the Chicago Council on Global Affairs' "Global Food For Thought" blog, Howarth Bouis, director of HarvestPlus, a global research program that develops and disseminates nutrient-rich staple food crops to improve nutrition globally, writes, "David Cameron's decision to tie a hunger summit to the Olympics was imaginative ... because Cameron saw how the Olympics, that celebrate the best of human athleticism and teamwork, could also be used to draw attention to those who will never ever come close to competing in an Olympics event."
Celgene Corporation and Avila Therapeutics, Inc., a privately held biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, today announced a definitive merger agreement under which Celgene Corporation will acquire Avila Therapeutics, Inc.
Using experimental models, researchers at Boston University School of Medicine (BUSM) showed that adenosine, a metabolite released when the body is under stress or during an inflammatory response, stops the process of adipogenesis, when adipose (fat) stem cells differentiate into adult fat cells.
› Verified 4 days ago
| Entity Name | Adrian W Jachens Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780263319 PECOS PAC ID: 6406252600 Enrollment ID: O20210914002367 |
News Archive
Researchers from 12 Spanish hospitals took part with the aim of uncovering clinical and prognostic characteristics in solid organ recipients with COVID-19. The conclusions underscore the need for strict preventive measures in the initial period after transplantation.
In this post in the Chicago Council on Global Affairs' "Global Food For Thought" blog, Howarth Bouis, director of HarvestPlus, a global research program that develops and disseminates nutrient-rich staple food crops to improve nutrition globally, writes, "David Cameron's decision to tie a hunger summit to the Olympics was imaginative ... because Cameron saw how the Olympics, that celebrate the best of human athleticism and teamwork, could also be used to draw attention to those who will never ever come close to competing in an Olympics event."
Celgene Corporation and Avila Therapeutics, Inc., a privately held biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, today announced a definitive merger agreement under which Celgene Corporation will acquire Avila Therapeutics, Inc.
Using experimental models, researchers at Boston University School of Medicine (BUSM) showed that adenosine, a metabolite released when the body is under stress or during an inflammatory response, stops the process of adipogenesis, when adipose (fat) stem cells differentiate into adult fat cells.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Adrian William Jachens, MD 1200 E Ridgewood Ave, Ridgewood, NJ 07450-3957 Ph: (201) 612-4400 | Dr Adrian William Jachens, MD 1200 E Ridgewood Ave, Ridgewood, NJ 07450-3957 Ph: (201) 612-4400 |
News Archive
Researchers from 12 Spanish hospitals took part with the aim of uncovering clinical and prognostic characteristics in solid organ recipients with COVID-19. The conclusions underscore the need for strict preventive measures in the initial period after transplantation.
In this post in the Chicago Council on Global Affairs' "Global Food For Thought" blog, Howarth Bouis, director of HarvestPlus, a global research program that develops and disseminates nutrient-rich staple food crops to improve nutrition globally, writes, "David Cameron's decision to tie a hunger summit to the Olympics was imaginative ... because Cameron saw how the Olympics, that celebrate the best of human athleticism and teamwork, could also be used to draw attention to those who will never ever come close to competing in an Olympics event."
Celgene Corporation and Avila Therapeutics, Inc., a privately held biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, today announced a definitive merger agreement under which Celgene Corporation will acquire Avila Therapeutics, Inc.
Using experimental models, researchers at Boston University School of Medicine (BUSM) showed that adenosine, a metabolite released when the body is under stress or during an inflammatory response, stops the process of adipogenesis, when adipose (fat) stem cells differentiate into adult fat cells.
› Verified 4 days ago
Murray A Wolkstein, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 200 S Broad St Unit B, Ridgewood, NJ 07450 Phone: 201-445-6622 Fax: 201-445-0262 | |
Dr. Kiran Bhagwan Amesur, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 947 Linwood Ave, Suite 2 South, Ridgewood, NJ 07450 Phone: 201-857-4751 Fax: 201-857-4752 | |
Dr. Rony Gelman, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1200 E Ridgewood Ave, Ridgewood, NJ 07450 Phone: 201-612-9600 | |
Dr. Lisa Marie Gudicello, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 440 Northern Pkwy, Ridgewood, NJ 07450 Phone: 201-220-2654 Fax: 201-220-2654 | |
Dr. Larisa Kayserman, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1200 E Ridgewood Ave, Ridgewood, NJ 07450 Phone: 201-612-9600 Fax: 201-612-0428 | |
Dr. Anne R Sumers, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1200 E Ridgewood Ave, Ridgewood, NJ 07450 Phone: 201-612-0044 Fax: 201-612-9446 |